Lapix

Developer of immunotherapies for immunological diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups9 employees language lapix.com

Registered entities

Social engagement

Social engagement: 1.4K social following, 2 posts in the last 12 months — below the industry typical range.

Recent activity

23 Dec 2025
Milestone
regulatory
11 Dec 2025
Product launch
LPXTI641 oral capsule and a new, higher NOAEL in GLP toxicology studies
Coming soon